4//SEC Filing
Durham Mark Andrew 4
Accession 0001502213-10-000005
CIK 0000885590other
Filed
Nov 14, 7:00 PM ET
Accepted
Nov 15, 7:40 PM ET
Size
8.8 KB
Accession
0001502213-10-000005
Insider Transaction Report
Form 4
Durham Mark Andrew
SVP, Human Resources
Transactions
- Award
Stock Options (right to purchase)
2010-11-11+60,000→ 60,000 totalExercise: $26.41Exp: 2015-11-11→ Common Shares, no par value (60,000 underlying) - Award
Restricted Share Units
2010-11-11+30,000→ 30,000 total→ Common Shares, no par value (30,000 underlying)
Footnotes (3)
- [F1]The Stock Options vest in four equal annual installments commencing on October 8, 2011.
- [F2]Each Restricted Share Unit (RSU) represents a contingent right to receive between zero and three common shares, no par value, of Valeant Pharmaceuticals International, Inc., subject to performance based vesting criteria. See note (3)
- [F3]The performance based RSUs will vest based on total shareholder return (TSR) between a price of $26.51 starting on September 28, 2010 and the average stock price for the prior 20 trading days as of three measurement dates: 25% would vest on June 28, 2013, 50% on September 28, 2013 and 25% on December 28, 2013. Unit vesting is contingent on TSR performance between 15% and 45% into between one and three shares of common stock, respectively, with early vesting possible at higher TSR levels.
Documents
Issuer
Valeant Pharmaceuticals International, Inc.
CIK 0000885590
Entity typeother
Related Parties
1- filerCIK 0001477126
Filing Metadata
- Form type
- 4
- Filed
- Nov 14, 7:00 PM ET
- Accepted
- Nov 15, 7:40 PM ET
- Size
- 8.8 KB